{"entity":{"type":"insider","cik":"0001746830","url":"/insider/0001746830","json_url":"/insider/0001746830.json","name":"Agarwal Shefali","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2019-06-17","last":"2022-06-08","span_basis":"filed_date"},"name_variants":[{"name":"Agarwal Shefali","source":"filing","n_filings":14,"first_seen":"2019-06-17","last_seen":"2022-06-08"}],"transactions":[{"id":6785229,"accession":"0001209191-22-034996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-034996","line_url":"/filing/0001209191-22-034996#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":841.0,"shares_display":"841","price_per_share":21.89,"price_display":"21.89","price_state":"stated","total_value":18409.49,"total_display":"18,409.49","shares_owned_after":1840.0,"shares_owned_after_display":"1,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-08","scope":"insider"},{"id":9271750,"accession":"0001209191-22-034992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-034992","line_url":"/filing/0001209191-22-034992#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":0.0,"shares_display":"0","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"shares_owned_after":2681.0,"shares_owned_after_display":"2,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-08","scope":"insider"},{"id":6148502,"accession":"0001209191-22-034536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-034536","line_url":"/filing/0001209191-22-034536#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":807.0,"shares_display":"807","price_per_share":22.8,"price_display":"22.80","price_state":"stated","total_value":18399.6,"total_display":"18,399.60","shares_owned_after":1874.0,"shares_owned_after_display":"1,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-03","filed_date":"2022-06-06","scope":"insider"},{"id":6442880,"accession":"0000899243-22-005470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-005470","line_url":"/filing/0000899243-22-005470#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1058.0,"shares_display":"1,058","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":1587.0,"total_display":"1,587.00","shares_owned_after":156385.0,"shares_owned_after_display":"156,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider"},{"id":6973425,"accession":"0000899243-22-004829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-004829","line_url":"/filing/0000899243-22-004829#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2639.0,"shares_display":"2,639","price_per_share":1.37,"price_display":"1.37","price_state":"stated","total_value":3615.43,"total_display":"3,615.43","shares_owned_after":157443.0,"shares_owned_after_display":"157,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-04","scope":"insider"},{"id":6471151,"accession":"0000899243-22-003557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-003557","line_url":"/filing/0000899243-22-003557#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2922.0,"shares_display":"2,922","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":5902.44,"total_display":"5,902.44","shares_owned_after":160082.0,"shares_owned_after_display":"160,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-26","filed_date":"2022-01-28","scope":"insider"},{"id":5088084,"accession":"0000899243-21-047205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-047205","line_url":"/filing/0000899243-21-047205#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1780.0,"shares_display":"1,780","price_per_share":2.93,"price_display":"2.93","price_state":"stated","total_value":5215.4,"total_display":"5,215.40","shares_owned_after":163004.0,"shares_owned_after_display":"163,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider"},{"id":5517987,"accession":"0000899243-21-005043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-005043","line_url":"/filing/0000899243-21-005043#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":969.0,"shares_display":"969","price_per_share":11.21,"price_display":"11.21","price_state":"stated","total_value":10862.49,"total_display":"10,862.49","shares_owned_after":104341.0,"shares_owned_after_display":"104,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":5029482,"accession":"0000899243-21-003529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-003529","line_url":"/filing/0000899243-21-003529#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2872.0,"shares_display":"2,872","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":32769.52,"total_display":"32,769.52","shares_owned_after":75727.0,"shares_owned_after_display":"75,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider"},{"id":2169946,"accession":"0000899243-20-032831","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-032831","line_url":"/filing/0000899243-20-032831#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2522.0,"shares_display":"2,522","price_per_share":13.54,"price_display":"13.54","price_state":"stated","total_value":34147.88,"total_display":"34,147.88","shares_owned_after":76089.0,"shares_owned_after_display":"76,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-07","scope":"insider"},{"id":2376045,"accession":"0000899243-20-017901","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017901","line_url":"/filing/0000899243-20-017901#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1805.0,"shares_display":"1,805","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":29150.75,"total_display":"29,150.75","shares_owned_after":78611.0,"shares_owned_after_display":"78,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-06-30","scope":"insider"},{"id":3194990,"accession":"0000899243-20-009604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-009604","line_url":"/filing/0000899243-20-009604#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1243.0,"shares_display":"1,243","price_per_share":15.28,"price_display":"15.28","price_state":"stated","total_value":18993.04,"total_display":"18,993.04","shares_owned_after":71991.0,"shares_owned_after_display":"71,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-26","scope":"insider"},{"id":3275062,"accession":"0000899243-20-002116","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-002116","line_url":"/filing/0000899243-20-002116#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2630.0,"shares_display":"2,630","price_per_share":20.44,"price_display":"20.44","price_state":"stated","total_value":53757.2,"total_display":"53,757.20","shares_owned_after":58803.0,"shares_owned_after_display":"58,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-27","scope":"insider"},{"id":3275058,"accession":"0000899243-20-002116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-002116","line_url":"/filing/0000899243-20-002116#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1843.0,"shares_display":"1,843","price_per_share":24.64,"price_display":"24.64","price_state":"stated","total_value":45411.52,"total_display":"45,411.52","shares_owned_after":61433.0,"shares_owned_after_display":"61,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-24","filed_date":"2020-01-27","scope":"insider"},{"id":7879745,"accession":"0000899243-19-017213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-017213","line_url":"/filing/0000899243-19-017213#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001746830","owner_name":"Agarwal Shefali","owner_url":"/insider/0001746830","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1195.0,"shares_display":"1,195","price_per_share":11.97,"price_display":"11.97","price_state":"stated","total_value":14304.15,"total_display":"14,304.15","shares_owned_after":35699.0,"shares_owned_after_display":"35,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Director","n_filings":3,"first_seen":"2022-06-06","last_seen":"2022-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Officer","n_filings":11,"first_seen":"2019-06-17","last_seen":"2022-02-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001746830","retrieved_at":"2026-08-21T11:39:13+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}